Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1123367,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1123367/?format=api",
    "text_counter": 411,
    "type": "speech",
    "speaker_name": "Isiolo South, KPP",
    "speaker_title": "Hon. Abdi Tepo",
    "speaker": {
        "id": 13350,
        "legal_name": "Abdi Koropu Tepo",
        "slug": "abdi-koropu-tepo-2"
    },
    "content": " Thank you, Hon. Temporary Deputy Speaker. I beg to move the following Motion: THAT this House adopts the Report of the Committee on Delegated Legislation on its consideration of the Breast Milk Substitutes (Regulations and Controls) (General) Regulations, 2021, laid on the Table of the House on Wednesday, 10th November 2021, and pursuant to the provisions of Section 28 (5) of the Breast Milk Substitutes (Regulation and Control) Act, 2012 approves the Breast Milk Substitutes (Regulations and Controls) (General) Regulations, 2021, published as Legal Notice No. 184 of 2021 with amendments to Regulations 1, 2 and 27 (1). The Breast Milk Substitutes (Regulation and Control) (General) Regulations 2021, have been made by the Cabinet Secretary for Health in exercise of powers conferred by Section 28 of the Breast Milk Substitutes Act, 2012. The regulations were published in the Gazette on 27th August 2021, submitted to the Clerk of the National Assembly on 5th October 2021 and laid in the House on 6th October 2021, being within the requisite statutory timelines under Section 11 (1) of the Statutory Instruments Act. Hon. Temporary Deputy Speaker, the purpose and the object of the regulation was to: First, give full effect to Breast Milk Substitutes Act, 2012, and more particularly, Regulation 6 to reduce preventable illness and deaths of young children through protection, promotion and support of optimal breastfeeding and complementary feeding. Secondly, to promote and protect the best interest of an infant and young children and finally, to guide the ethical interaction of manufacturers with health workers on the manner in which donations are used or received, demonstrations on use, development of informal and educational communication materials and labelling of Breast Milk Substitutes (BMS) Act. Pursuant to Section 16…"
}